跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CSL US AlbuRx 5 human albumin 50 g/L (5% w/v) solution for intravenous infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
CSL US AlbuRx 5 human albumin 50 g/L (5% w/v) solution for intravenous infusion vial
Approved
STANDARD
CSL US AlbuRx 5 human albumin 50 g/L (5% w/v) solution for intravenous infusion vial
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d5c763511bb70c3f
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
d5c763511bb70c3f
Product Name
CSL US AlbuRx 5 human albumin 50 g/L (5% w/v) solution for intravenous infusion vial
Artg Id
470325
Artg Name
CSL US AlbuRx 5 human albumin 50 g/L (5% w/v) solution for intravenous infusion vial
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2024-11-25
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d5c763511bb70c3f
Type
Standard
Back to TGA Approvals